141 related articles for article (PubMed ID: 15331126)
1. Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alpha.
Schaefer M; Horn M; Schmidt F; Schmid-Wendtner MH; Volkenandt M; Ackenheil M; Mueller N; Schwarz MJ
Brain Behav Immun; 2004 Nov; 18(6):555-62. PubMed ID: 15331126
[TBL] [Abstract][Full Text] [Related]
2. Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial.
Heinze S; Egberts F; Rötzer S; Volkenandt M; Tilgen W; Linse R; Boettjer J; Vogt T; Spieth K; Eigentler T; Brockmeyer NH; Hinzpeter A; Hauschild A; Schaefer M
J Immunother; 2010 Jan; 33(1):106-14. PubMed ID: 19952950
[TBL] [Abstract][Full Text] [Related]
3. Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy.
Capuron L; Ravaud A; Miller AH; Dantzer R
Brain Behav Immun; 2004 May; 18(3):205-13. PubMed ID: 15050647
[TBL] [Abstract][Full Text] [Related]
4. Effects of rIFN-beta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells.
Trojano M; Defazio G; Avolio C; Paolicelli D; Giuliani F; Giorelli M; Livrea P
J Neurovirol; 2000 May; 6 Suppl 2():S47-51. PubMed ID: 10871785
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma.
Friebe A; Horn M; Schmidt F; Janssen G; Schmid-Wendtner MH; Volkenandt M; Hauschild A; Goldsmith CH; Schaefer M
Psychosomatics; 2010; 51(6):466-73. PubMed ID: 21051677
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma.
Friebe A; Schwarz MJ; Schmid-Wendtner M; Volkenandt M; Schmidt F; Horn M; Janssen G; Schaefer M
J Immunother; 2007 Apr; 30(3):333-7. PubMed ID: 17414324
[TBL] [Abstract][Full Text] [Related]
7. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
8. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
Guillot B; Portalès P; Thanh AD; Merlet S; Dereure O; Clot J; Corbeau P
Br J Dermatol; 2005 Apr; 152(4):690-6. PubMed ID: 15840100
[TBL] [Abstract][Full Text] [Related]
9. Management of hypertriglyceridemia in patients receiving interferon for malignant melanoma.
Wong SF; Jakowatz JG; Taheri R
Ann Pharmacother; 2004 Oct; 38(10):1655-9. PubMed ID: 15304625
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon.
Bouwhuis MG; Suciu S; Collette S; Aamdal S; Kruit WH; Bastholt L; Stierner U; Salès F; Patel P; Punt CJ; Hernberg M; Spatz A; ten Hagen TL; Hansson J; Eggermont AM;
J Natl Cancer Inst; 2009 Jun; 101(12):869-77. PubMed ID: 19509353
[TBL] [Abstract][Full Text] [Related]
11. Major depression and risk of depressive symptomatology associated with short-term and low-dose interferon-alpha treatment.
Beratis S; Katrivanou A; Georgiou S; Monastirli A; Pasmatzi E; Gourzis P; Tsambaos D
J Psychosom Res; 2005 Jan; 58(1):15-8. PubMed ID: 15771865
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
[TBL] [Abstract][Full Text] [Related]
13. Self-efficacy for coping with cancer in melanoma patients: its association with physical fatigue and depression.
Albrecht K; Droll H; Giesler JM; Nashan D; Meiss F; Reuter K
Psychooncology; 2013 Sep; 22(9):1972-8. PubMed ID: 23288588
[TBL] [Abstract][Full Text] [Related]
14. [Serum levels of soluble intercellular adhesion molecule 1 in malignant lymphoproliferative disorders].
Li D; Li G; Cui W
Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):232-4. PubMed ID: 11601209
[TBL] [Abstract][Full Text] [Related]
15. Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.
Capuron L; Raison CL; Musselman DL; Lawson DH; Nemeroff CB; Miller AH
Am J Psychiatry; 2003 Jul; 160(7):1342-5. PubMed ID: 12832253
[TBL] [Abstract][Full Text] [Related]
16. [Sarcoidosis, myasthenia gravis and anterior ischaemic optic neuropathy: severe side effects of adjuvant interferon-alpha-therapy in malignant melanoma?].
Kreutzer K; Bonnekoh B; Franke I; Ulrich J; Gollnick H
J Dtsch Dermatol Ges; 2004 Aug; 2(8):689-94. PubMed ID: 16279234
[TBL] [Abstract][Full Text] [Related]
17. Elevation of plasma concentration of adhesion molecules in late-life depression.
Dimopoulos N; Piperi C; Salonicioti A; Mitsonis C; Liappas I; Lea RW; Kalofoutis A
Int J Geriatr Psychiatry; 2006 Oct; 21(10):965-71. PubMed ID: 16927406
[TBL] [Abstract][Full Text] [Related]
18. Association of mineral metabolism with an increase in cellular adhesion molecules: another link to cardiovascular risk in maintenance haemodialysis?
Arici M; Kahraman S; Gençtoy G; Altun B; Kalyoncu U; Oto A; Kirazli S; Erdem Y; Yasavul U; Turgan C
Nephrol Dial Transplant; 2006 Apr; 21(4):999-1005. PubMed ID: 16326734
[TBL] [Abstract][Full Text] [Related]
19. Severe malaria in Cameroonian children: correlation between plasma levels of three soluble inducible adhesion molecules and TNF-alpha.
Tchinda VH; Tadem AD; Tako EA; Tene G; Fogako J; Nyonglema P; Sama G; Zhou A; Leke RG
Acta Trop; 2007 Apr; 102(1):20-8. PubMed ID: 17397790
[TBL] [Abstract][Full Text] [Related]
20. A case of malignant melanoma: disease progression correlated with serum levels of 5-S-Cysteinyldopa (5-S-CD) and intercellular adhesion molecule-1 (ICAM-1).
Ye Z; Kageshita T; Ishihara T; Ito S; Ono T
J Dermatol; 1995 May; 22(5):370-5. PubMed ID: 7673560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]